 |
|
Cystoid Macular Edema Associated With Latanoprost Use
Arch Ophthalmol. 1998;116:680-682.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Latanoprost is a prostaglandin analog that is being used to reduce intraocular pressure in patients with glaucoma. The convenience of its once-a-day dosing, relative safety, and apparent efficacy have resulted in wide acceptance of latanoprost as a valuable adjunct in the treatment of glaucoma.1
Common adverse effects of latanoprost use include conjunctival hyperemia, topical irritation, and changes in iris pigmentation.2 We report a case in which cystoid macular edema (CME) occurred after the initiation of topical latanoprost. The CME resolved after discontinuation of the drug, without additional intervention.
Report of a Case
An 81-year-old white woman had decreased vision in the left eye 3 weeks after being prescribed latanoprost for chronic open-angle glaucoma. Her ocular history, in addition to glaucoma, was remarkable for pseudophakic bullous keratopathy after cataract extraction of the left eye in 1993 with placement of an anterior chamber intraocular lens because of intraoperative capsular rupture. She underwent penetrating keratoplasty and intraocular . . . [Full Text of this Article]
Comment
Corresponding author: Jeffrey S. Heier, MD, Retina Vitreous Associates, 7305 W Jefferson Blvd, Fort Wayne, IN 46804.
|
